Amgen (AMGN) Other Non-Current Liabilities (2009 - 2026)

Amgen (AMGN) has reported Other Non-Current Liabilities for 18 consecutive years, with $2.8 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 25.07% year-over-year to $2.8 billion; the TTM figure through Mar 2026 stood at $2.8 billion (up 25.07% YoY), while the FY2025 annual figure was $2.4 billion, up 1.23% from the prior year.
• Other Non-Current Liabilities came in at $2.8 billion for Q1 2026 at Amgen, up from $2.4 billion in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $6.7 billion in Q1 2022, with the low at $96.0 million in Q1 2024.
• Average Other Non-Current Liabilities over 5 years is $2.2 billion, with a median of $2.2 billion recorded in 2025.
• Across the five-year window, Other Non-Current Liabilities plunged 96.59% in 2023 and jumped 2202.08% in 2025, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $270.0 million in 2022, then soared by 1633.33% to $4.7 billion in 2023, then plunged by 49.81% to $2.3 billion in 2024, then advanced by 1.23% to $2.4 billion in 2025, then rose by 16.23% to $2.8 billion in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $2.8 billion, $2.4 billion, and $2.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.